Incidence, 30-day readmission rates and predictors of readmission after new onset atrial fibrillation who underwent transcatheter aortic valve replacement

• Published in: Heart & lung 2020-03, Vol.49 (2), p.186-192
• Main Authors: Doshi, Rajkumar, Pisipati, Sailaja, Taha, Mohamed, Dave, Mihir, Shah, Jay, Adalja, Devina, Gullapalli, Nageshwara
• Format: Article
• Language: English
• Subjects: New-onset atrial fibrillation; Readmission; Stroke; Transcatheter aortic valve replacement
• ISSN: 0147-9563; 1527-3288
• DOI: 10.1016/j.hrtlng.2019.10.011

•NOAF rate after TAVR was higher compared to previous studies and was ∼ 45% in this study.•Readmission rates were significantly higher in those patients who developed NOAF after TAVR.•There was a reducing trend in the rate of readmissions from 2012 to 2015 among the NOAF group.•Patients who developed NOAF had a higher rate of ischemic strokes within 30 days. New onset Atrial Fibrillation (NOAF) is frequently seen post transcatheter aortic valve replacement (TAVR). NOAF in the setting of TAVR has also been recognized as predictor of worse outcomes, including higher readmission rates. Data assessing the effect and predictors of NOAF on 30-day readmission rates post TAVR is limited. To assess the incidence, 30-day readmission rate and predictors of NOAF in patients who underwent TAVR. Nationwide Readmissions Database was used to identify patients who developed NOAF post-TAVR between 2012 and 2015. A total of 24,076 patients were included in this study, of which 54% were males, and the mean age was 82.4 ± 7.2. NOAF was developed in 10,847 (45%) patients. Overall readmission rates with NOAF was 19.7% and trend in the readmissions reduced during the course of the study (21.9% to 18.7%, Ptrend